Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590M
-
Number of holders
-
900
-
Total 13F shares, excl. options
-
173M
-
Shares change
-
+5.31M
-
Total reported value, excl. options
-
$31.9B
-
Value change
-
+$969M
-
Put/Call ratio
-
0.96
-
Number of buys
-
373
-
Number of sells
-
-432
-
Price
-
$184.74
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q2 2019
1,039 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q2 2019.
Edwards Lifesciences Corp - Common Stock (EW) has 900 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 173M shares
of 590M outstanding shares and own 29.26% of the company stock.
Largest 10 shareholders include BlackRock Inc. (16.5M shares), VANGUARD GROUP INC (16M shares), STATE STREET CORP (8.84M shares), FMR LLC (7.95M shares), SANDS CAPITAL MANAGEMENT, LLC (7.5M shares), Bank of New York Mellon Corp (6.81M shares), JENNISON ASSOCIATES LLC (6.04M shares), Capital Research Global Investors (5.12M shares), WELLINGTON MANAGEMENT GROUP LLP (4.81M shares), and ALLIANCEBERNSTEIN L.P. (4.36M shares).
This table shows the top 900 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.